New AI (Artificial Intelligence) model predicts heart failure hospitalizations
December 15, 2021 The Selene HF trial included more than 900 patients with a median age of 69 years old and a median ejection fraction of 30%. Eighty-one percent (81%) of participants were men. All patients had either an implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) manufactured by Bioronik. Each participant was enrolled … Read more